Botanix Pharmaceuticals Ltd has released a press release.
Response to ASX Price Query Letter
Filed with ASX ·
Watch Botanix Pharmaceuticals' latest callBotanix Pharmaceuticals (ASX:BOT) Q2 2026 Earnings Call · Replay · Mar 2Read the transcript of Botanix Pharmaceuticals (ASX:BOT) Q2 2026 Earnings Call6ix hasn’t read this filing yet.
Botanix Pharmaceuticals Limited on 6ix
Earlier from Botanix Pharmaceuticals
- Pause in trading
- March 2025 Quarterly Activities Report and Appendix 4C
- Botanix $40 Million Capital Raising for Sofdra Rollout
- Botanix Conference Commercial Update
- S&P DJI Announces March 2025 Quarterly Rebalance
Later from Botanix Pharmaceuticals
- Botanix Signs Debt Facility with Kreos Capital
- Botanix Provides Sofdra Launch Update
- June 2025 Quarterly Activities Report and Appendix 4C
- Response to ASX Aware Letter
- Appendix 4E & Annual Report for the Year Ended 30 June 2025
Follow Botanix Pharmaceuticals into a list and get an email when it puts out news.
Follow Botanix Pharmaceuticals